从环境灾害到新兴药物;一个框架来理解,绘制和评估与毒品有关的早期预警系统
J Freestone1, K J Siefried2, A Peacock3
1National Centre for Clinical Research on Emerging Drugs, Sydney, Australia; The National Drug and Alcohol Research Centre (NDARC), the University of New South Wales, Sydney, Australia.
The International journal on drug policy
|August 12, 2025
概括
现代药物预警系统 (EWS) 对于减轻不受监管的数字药物市场带来的风险至关重要. 该框架通过整合数据,改进响应,并让使用毒品的人参与进来,增强了EWS.
科学领域:
- 公共卫生 公共卫生
- 药物政策 药物政策
- 数字犯罪学数字犯罪学
背景情况:
- 在全球范围内,不受监管的药品市场正在扩大,越来越多地利用数字技术.
- 在非法市场上缺乏保证的物质成分和强度,这带来了重大风险,特别是在芬太尼和尼塔等合成阿片类药物方面.
- 早期预警系统 (EWS) 对于识别和减轻新出现的与毒品有关的危害至关重要.
研究的目的:
- 概述与毒品相关的现代EWS的组件,数据源,流程,利益相关者和输出.
- 评估目前与毒品相关的EWS实践与已建立的减少灾害风险的国际指南相比.
- 提出一个框架来开发,描述,评估和定制EWS.
主要方法:
- 分析数据来源,运营流程,利益相关方参与和当代与毒品有关的EWS产出的结果.
- 药物EWS实践与环境灾害风险降低EWS的四个关键子组件的比较:风险知识,检测/监测/预测,响应能力和警告通信.
- 考虑日常药物监测和地平线扫描如何可以加强EWS.
主要成果:
- 与药物相关的EWS通常与四个核心组件保持一致,但需要改进以获得最佳有效性.
- 常规药物监测和地平线扫描为积极减少危害提供了有价值的数据.
- 对吸毒者的有意义的参与对于数据收集,解释和响应有效性至关重要.
结论:
- 提出了一个结构化的框架,以指导与毒品有关的EWS的开发,评估和调整.
- 增强的EWS,包括多种数据流和利益相关者的投入,对于应对不断变化的药物市场威胁至关重要.
- 有效的药物早期预警系统需要合作,并纳入最终用户的观点,以全面减少危害.
相关概念视频
Pharmacovigilance
993
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
993
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Drug Control Governance: Regulatory Bodies and Their Impact
241
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
241
Drug Administration and Therapy Phases: Overview
743
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
743


